维普中文期刊产品整合服务
20篇 您的检索式:作者名="Reiman S"
    题名 作者 年代 出处 被引量
1美国国立老化研究所与阿尔茨海默病协会诊断指南写作组:阿尔茨海默病临床前阶段的定义显示文摘阿尔茨海默病(AD)的病理生理过程在痴呆诊断的多年前就开始了。这一长期的AD“临床前”阶段是治疗干预的关键机会,但需进一步阐明AD的病理级联过程和临床症状出现之间的联系。美国国立老化研究所和AD协会召集了一个国际工作组对AD生物标志物、流行病学和神经心理学的证据进行综述并提出建议,以确定能够预测由“正常”认知到轻度认知功能障碍(MCI)及AD痴呆的最佳预测指标。根据目前已有的主要科学证据,我们提出了一个概念性的框架和用于操作的研究标准,以通过纵向临床研究来验证和改进这些模型。这些建议仅用于研究目的,目前不涉及临床应用。我们希望这些建议能提供一个共识,以推进临床前AD的研究,最终推动更早期治疗干预的进展,使得一些疾病减缓药物的疗效发挥最大。Sperling RA Aisen PS Beckett LA Bennett DA Craft S Fagan AM Iwatsubo T Jack CR Jr Kaye J Montine TJ Park DC Reiman EM Rowe CC Siemers E Stern Y Yaffe K Carrillo MC Thies B Morrison-Bogorad M Wagster MV Phelps CH 贾建平(译) 郭起浩(译) 黄丽(译) 陆璐(译) 张逸驰(译) 邢怡(译) 2012中华神经科杂志2012,45,5:22
2Dimensioning large call centers显示文摘Borst S Mandelbaum A Reiman M 0,,01:1
3Central nervous system targeted exp ression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis显示文摘Davoust N Nataf S Reiman R 1999Immunol1999,163,12:1
4The role of beta III tubulin inpredicting chemoresistance in non-small cell lung cancer显示文摘Sève P Reiman T Dumontet C 2010LungCancer2010,67,2:1
5Central nervous sytem-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis 显示文摘Davoust N Nataf S Reiman R 1999Immunol1999,,12:1
6Cross-validation study of class HI beta tubulin as a predictive marker for benefit from adiuvant chemotherapy in resected non-small cell lung cancer: analysis of four randomized trials显示文摘REIMAN T LAI R VEILLARD A S 2012Ann Oncol2012,23,1:1
7The role ofbetaⅢβ-tubu-lin in predicting chemoresistance in non-small cell lung cancer显示文摘Sève P Reiman T Dumontet C 2010Lung Cancer2010,67,2:1
8Class III β-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site显示文摘Pascal Sève Tony Reiman Raymond Lai John Hanson Cheryl Santos Lorelei Johnson Laith Dabbagh Michael Sawyer Charles Dumontet John R. Mackey 2007Cancer Chemotherapy and Pharmacology2007,,1:1
9The new medical - industrial complex显示文摘Reiman A S 1980New EnglandJournal of Medicine1980,303,:1
10Is Downtown Mainly for Tourists?显示文摘Snepenger D J Reiman S Johnson J 1998Journal of Travel Research1998,36,3:1
11Central nervous sytem - targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis显示文摘Davoust N Nataf S Reiman R 1999J Immunol1999,163,:1
12Alzheimer's Prevention Initiative: a plan to accelerate theevaluation of presymptomatic treatments显示文摘REIMAN E M LANGBAUM J B S FLEISHER A S 2011J Alzheimers Dis2011,26,3:1
13Alzheimer' s disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons 显示文摘Liang W S Reiman E M Valla J 2008Proc Natl Aead Sci USA2008,105,11:1
14Class Ⅲ beta-tubulin is a marker of paclitaxel resistance in carcinomas of unknown primary site显示文摘Sève P Reiman T Lai R 2007Cancer Chemother Pharmacol2007,60,:1
15A low- power resonant micromachined compass 显示文摘Leichle T C Arxl M V Reiman S 2004Journal of Micromechanics and Microengineering2004,14,4:1
16Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis 显示文摘Davoust N Nataf S Reiman R 1999J Immunol1999,163,12:1
17Immunoglobulin G antibodies to moulds in school-children from moisture problem schools显示文摘Taskinen TM Laitinen S Nevalainen A Vepsalainen A Meklin T Reiman M 2002Allergy2002,57,1:1
18Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia显示文摘Adarnia S Treon SP Reiman T 2005Clin Lymphoma2005,5,4:1
19Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons显示文摘Winnie S Liang Eric M Reiman Jon Valla 0,,:1
20Protein abundance of class III beta-tubulin but not Delta2-alpha-tubulin or tau is related to paclitaxel response in carcinomas of unknown primary site显示文摘Sève P Reiman T Isaac S 2008Anticancer Res2008,28,2:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费